Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?

Tomljenovic L, Shaw CA.

Ann Med. 2013 Mar;45(2):182-93. doi: 10.3109/07853890.2011.645353. Review.

PMID:
22188159
2.

Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?

Fastrez M, Naik HN, Corfers A, Rozenberg S.

Ann Med. 2012 Jun;44(4):404. doi: 10.3109/07853890.2012.671539. No abstract available.

PMID:
22462602
3.

Efficacy and other milestones for human papillomavirus vaccine introduction.

Pagliusi SR, Teresa Aguado M.

Vaccine. 2004 Dec 16;23(5):569-78. Review.

PMID:
15630792
4.

The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.

Brinkman JA, Caffrey AS, Muderspach LI, Roman LD, Kast WM.

Eur J Gynaecol Oncol. 2005;26(2):129-42. Review.

PMID:
15857016
5.

Human Pappilomavirus (HPV) induced cancers and prevention by immunization.

Khaliq SA, Shyum Naqvi SB, Fatima A.

Pak J Pharm Sci. 2012 Oct;25(4):763-72.

PMID:
23009992
6.
7.

Vaccines against human papillomavirus and cervical cancer: promises and challenges.

Mahdavi A, Monk BJ.

Oncologist. 2005 Aug;10(7):528-38. Review.

9.

[Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].

Monsonego J.

Presse Med. 2007 Apr;36(4 Pt 2):640-66. Review. French. Erratum in: Presse Med. 2007 Jul-Aug;36(7-8):1150-1.

PMID:
17350792
10.

[Human papillomavirus prophylactic vaccines: stakes and perspectives].

Hantz S, Alain S, Denis F.

Gynecol Obstet Fertil. 2006 Jul-Aug;34(7-8):647-55. Review. French.

PMID:
16807045
11.

[Cervical cancer prevention: the impact of HPV vaccination].

Monsonégo J.

Gynecol Obstet Fertil. 2006 Mar;34(3):189-201. Review. French.

PMID:
16529969
13.

Implementation of human papillomavirus immunization in the developing world.

Kane MA, Serrano B, de Sanjosé S, Wittet S.

Vaccine. 2012 Nov 20;30 Suppl 5:F192-200. doi: 10.1016/j.vaccine.2012.06.075. Review.

PMID:
23199963
14.

Preventive and therapeutic HPV vaccines.

Monie A, Hung CF, Wu TC.

Curr Opin Investig Drugs. 2007 Dec;8(12):1038-50. Review.

PMID:
18058574
15.

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

Kaufmann AM, Stern PL, Rankin EM, Sommer H, Nuessler V, Schneider A, Adams M, Onon TS, Bauknecht T, Wagner U, Kroon K, Hickling J, Boswell CM, Stacey SN, Kitchener HC, Gillard J, Wanders J, Roberts JS, Zwierzina H.

Clin Cancer Res. 2002 Dec;8(12):3676-85.

16.

[What should be known for the introduction of an HPV vaccine?].

Muñoz N, Jacquard AC.

Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Review. French.

PMID:
18786806
17.

Education about human papillomavirus and human papillomavirus vaccines in adolescents.

Kollar LM, Kahn JA.

Curr Opin Obstet Gynecol. 2008 Oct;20(5):479-83. doi: 10.1097/GCO.0b013e32830d0cf6. Review.

PMID:
18797272
18.

Planning for the HPV vaccine and its impact on cervical cancer prevention.

Bailey J, Cymet TC.

Compr Ther. 2006 Summer;32(2):102-5.

PMID:
16845153
19.

Vaccination against human papillomavirus.

BMJ Group..

Drug Ther Bull. 2008 Dec;46(12):89-93. Review.

PMID:
19056700
20.

Introducing human papillomavirus vaccines - questions remain.

Paavonen J, Lehtinen M.

Ann Med. 2008;40(3):162-6. doi: 10.1080/07853890701802404. Review.

PMID:
18382882
Items per page

Supplemental Content

Support Center